Article

Combination of minimal residual disease and 123 I-Metaiodobenzylguanidine scintigraphy in monitoring of neuroblastoma metastases

2024-05-09

Abstract excerpt

<h4>Background: </h4> Accurate and early detection of neuroblastoma (NB) metastases is an urgent requirement for clinical diagnosis and treatment. This study aimed to explore the value of a new diagnostic model combining 123 I - Metaiodobenzylguanidine (MIBG) scintigraphy, minimal residual disease (MRD) examination and clinical parameters in detecting metastases of NB. <h4>Methods: </h4>: A total of 76 pediatri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a5d50e11-7ad2-5533-b9fb-6abcf196fa88
DOI: 10.22541/au.171524013.37115338/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combination of minimal residual disease and 123 I-Metaiodobenzylguanidine scintigraphy in monitoring of neuroblastoma metastasesDOI 10.22541/au.171524013.37115338/v1Read

Risk of Developing Second Malignant Neoplasms in Patients with Neuroblastoma: A Population Study of the US SEER DatabaseSemantic proximity Read

Evaluation of Minimal Residual Disease in Patients with NeuroblastomaSemantic proximity Read

Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCRSemantic proximity Read

Chromosome 10 Abnormality Predicts Prognosis of Neuroblastoma Patients With Bone Marrow Metastasischromosome 10 Abnormality Predicts Prognosis of Neuroblastoma Patients With Bone Marrow MetastasisSemantic proximity Read

Nothing but NET: A review of norepinephrine transporter expression and efficacy of<sup>131</sup>I‐mIBG therapySemantic proximity Read

Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.Semantic proximity Read

Clinical value of 18F-FDG PET/CT to predict MYCN gene, chromosome 1p36 and 11q status in pediatric neuroblastoma and ganglioneuroblastomaSemantic proximity Read

Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NETSemantic proximity Read

Clinical characteristics and prognosis of 40 patients with periorbital metastasis of neuroblastomaSemantic proximity Read

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology GroupSemantic proximity Read

MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastomaSemantic proximity Read

PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in NeuroblastomaSemantic proximity Read